---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004329"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T05:03:29.484968+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health appoints Michael Buhle as CEO, James Crawford as VP of Finance

## Summary
- Michael Buhle appointed CEO, adds role to current Chief Commercial Officer duties; effective Jan 28, 2025.
- James Crawford appointed VP of Finance, serving as principal financial and accounting officer; joined Aspira in 2021.
- Interim CEO Dr. Sandra Milligan remains President of the Company.
- No family relationships or material interests with existing directors or officers per Regulation S-K.

## SEC filing metadata
- accession: 0001493152-25-004329
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004329
- JSON: https://secwatch.observer/filing/0001493152-25-004329.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004329.txt

## Key facts
- Executive change
  James Crawford was appointed as Vice President of Finance at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Vice President of Finance
  source text: In addition, on January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed James Crawford as the Company’s Vice President of Finance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm
- Executive change
  Michael Buhle was appointed as Chief Executive Officer at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Michael Buhle as the Company’s Chief Executive Officer in addition to his current duties as Chief Commercial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.